4-Epi Minocycline (CAS 43168-51-0)
See product citations (1)
QUICK LINKS
4-Epi Minocycline is a tetracycline and is the 4-epimer of minocycline. In research applications, it is utilized to study the structure-activity relationships of tetracycline compounds. Its utilization in research helps in understanding the biochemical kinetics and mechanisms of minocycline and its related compounds. 4-Epi Minocycline is often used as a reference compound for analytical methods aimed at quantifying minocycline and its metabolites in biological samples. Additionally, it serves in comparative studies to assess the differences in biological activity between it and its parent compound, minocycline. Research involving 4-Epi Minocycline is also significant in the synthesis of new tetracycline derivatives and the exploration of their potential biological effects.
4-Epi Minocycline (CAS 43168-51-0) References
- Liquid chromatography for the quantitative analysis of antibiotics--some applications using poly(styrene-divinylbenzene). | Hoogmartens, J. 1992. J Pharm Biomed Anal. 10: 845-50. PMID: 1298392
- Validated stability-indicating densitometric thin-layer chromatography: application to stress degradation studies of minocycline. | Jain, N., et al. 2007. Anal Chim Acta. 599: 302-9. PMID: 17870294
- Diagnostic criteria for autoimmune hepatitis: what is the gold standard? | Kochar, R. and Fallon, M. 2010. Hepatology. 51: 350-1; author reply 351. PMID: 20034043
- Analysis of a second-generation tetracycline antibiotic minocycline in human plasma by LC-MS/MS. | Patel, DS., et al. 2011. Bioanalysis. 3: 2177-94. PMID: 21985413
- Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa. | Chen, Q., et al. 2019. Mol Pharm. 16: 1606-1619. PMID: 30817887
- Topical minocycline formulations: Evaluation and comparison of dermal uptake efficacy. | Lac, D., et al. 2019. Int J Pharm X. 1: 100009. PMID: 31517274
- Novel Therapeutic Strategies Applied to Pseudomonas aeruginosa Infections in Cystic Fibrosis. | Chirgwin, ME., et al. 2019. Materials (Basel). 12: PMID: 31817881
- Separation and detection of tetracyclines by high-speed liquid chromatography. | Butterfield, AG., et al. 1973. Antimicrob Agents Chemother. 4: 11-5. PMID: 4791479
- Metabolism and tissue distribution of radioisotopically labelled minocycline. | Kelly, RG. and Kanegis, LA. 1967. Toxicol Appl Pharmacol. 11: 171-83. PMID: 6056150
- Assay and purity control of minocycline by thin-layer chromatography using UV and fluorescence densitometry--a comparison with liquid chromatography. | Naidong, W., et al. 1995. J Pharm Biomed Anal. 13: 905-10. PMID: 8562615
- Capillary zone electrophoresis of minocycline. | Li, YM., et al. 1996. J Pharm Biomed Anal. 14: 1095-9. PMID: 8818020
- In situ degradation: a new concept for system suitability tests in monographs of the European Pharmacopoeia. | Rose, U. 1998. J Pharm Biomed Anal. 18: 1-14. PMID: 9863938
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
4-Epi Minocycline, 0.5 mg | sc-210033A | 0.5 mg | $500.00 | |||
4-Epi Minocycline, 1 mg | sc-210033 | 1 mg | $918.00 | |||
4-Epi Minocycline, 5 mg | sc-210033B | 5 mg | $3927.00 | |||
4-Epi Minocycline, 10 mg | sc-210033C | 10 mg | $5518.00 |